• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在帕金森病模型中,α-突触核蛋白表达的降低促进早期神经病理学发展的减缓。

Reduction of the α-synuclein expression promotes slowing down early neuropathology development in the model of Parkinson's disease.

作者信息

Golomidov Ilia M, Latypova Evgenia M, Ryabova Elena V, Bolshakova Olga I, Komissarov Artem E, Sarantseva Svetlana V

机构信息

Petersburg Nuclear Physics Institute named by B.P.Konstantinov of NRC «Kurchatov Institute», Gatchina, Russia.

出版信息

J Neurogenet. 2022 Mar;36(1):1-10. doi: 10.1080/01677063.2022.2064462. Epub 2022 Apr 25.

DOI:10.1080/01677063.2022.2064462
PMID:35467466
Abstract

Parkinson's disease (PD) is a neurodegenerative disease characterised by the formation of Lewy bodies and progressive loss of dopaminergic (DA) neurons in the substantia nigra. Lewy bodies mainly consist of α-synuclein, which plays a critical role in the pathophysiology of PD. The α-synuclein is encoded by the gene and is the first identified gene associated with hereditary PD. Currently, there are at least six disease-associated mutations in α-synuclein that cause dominantly inherited familial forms of PD. Targeted expression of human gene in over specific times employing a temperature-dependent system allows for the evaluation of neurodegenerative processes. In this study, was expressed only in the adult stage of development for 1 or 2 weeks, followed by repression of gene expression for the rest of the fly's life. It was demonstrated that the level of pathology significantly depends on the duration of α-synuclein expression. gene expression over a longer period of time caused the death of DA neurons, decreased levels of dopamine and locomotor ability. In this case, the observed neurodegenerative processes correlated with the accumulation of α-synuclein in the brain. Importantly, repression of α-synuclein expression led to elimination of the soluble protein fraction, in contrast to the insoluble fraction. No further significant development of characteristic signs of pathology was observed after the α-synuclein expression was blocked. Thus, we suggest that reduction of α-synuclein expression alone contributes to slowing down the development of PD-like symptoms.

摘要

帕金森病(PD)是一种神经退行性疾病,其特征是路易小体的形成以及黑质中多巴胺能(DA)神经元的逐渐丧失。路易小体主要由α-突触核蛋白组成,它在帕金森病的病理生理学中起关键作用。α-突触核蛋白由该基因编码,是首个被鉴定出与遗传性帕金森病相关的基因。目前,α-突触核蛋白中至少有六种与疾病相关的突变,这些突变会导致显性遗传的家族性帕金森病形式。利用温度依赖性系统在特定时间内对果蝇进行人该基因的靶向表达,可用于评估神经退行性过程。在本研究中,该基因仅在果蝇发育的成年阶段表达1或2周,随后在果蝇的余生中抑制基因表达。结果表明,病理水平显著取决于α-突触核蛋白的表达持续时间。较长时间的该基因表达导致多巴胺能神经元死亡、多巴胺水平降低以及运动能力下降。在这种情况下,观察到的神经退行性过程与α-突触核蛋白在果蝇大脑中的积累相关。重要的是,与不溶性部分相比,α-突触核蛋白表达的抑制导致可溶性蛋白部分的消除。在α-突触核蛋白表达被阻断后,未观察到病理特征性体征的进一步显著发展。因此,我们认为仅降低α-突触核蛋白的表达有助于减缓帕金森病样症状的发展。

相似文献

1
Reduction of the α-synuclein expression promotes slowing down early neuropathology development in the model of Parkinson's disease.在帕金森病模型中,α-突触核蛋白表达的降低促进早期神经病理学发展的减缓。
J Neurogenet. 2022 Mar;36(1):1-10. doi: 10.1080/01677063.2022.2064462. Epub 2022 Apr 25.
2
α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.α-突触核蛋白 BAC 转基因小鼠表现出类似 RBD 的行为和嗅觉减退:一种前驱性帕金森病模型。
Brain. 2020 Jan 1;143(1):249-265. doi: 10.1093/brain/awz380.
3
Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.新型 A30P α-突触核蛋白 BAC 转基因小鼠多巴胺而非去甲肾上腺素信号的区域特异性缺陷。
Neurobiol Dis. 2014 Feb;62:193-207. doi: 10.1016/j.nbd.2013.10.005. Epub 2013 Oct 10.
4
Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.帕金森病患者(PARK4)中 SNCA 三重复制诱导多能干细胞源性多巴胺能神经元中的α-突触核蛋白动力学。
FEBS Open Bio. 2021 Feb;11(2):354-366. doi: 10.1002/2211-5463.13060. Epub 2021 Jan 5.
5
Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.突变型α-突触核蛋白过表达在帕金森病高危迷走运动神经元中诱导无应激性起搏。
J Neurosci. 2017 Jan 4;37(1):47-57. doi: 10.1523/JNEUROSCI.1079-16.2016.
6
The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain.溶酶体膜蛋白 LAMP2A 促进自噬流,防止 SNCA 诱导的果蝇大脑帕金森病样症状。
Autophagy. 2018;14(11):1898-1910. doi: 10.1080/15548627.2018.1491489. Epub 2018 Aug 10.
7
Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.脑内给予配体-ASO 缀合物可选择性降低双突变人 A30P*A53T*α-突触核蛋白转基因小鼠单胺能神经元中 α-突触核蛋白的积累。
Int J Mol Sci. 2021 Mar 13;22(6):2939. doi: 10.3390/ijms22062939.
8
rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.rAAV2/7 载体介导的小鼠黑质中 alpha-突触核蛋白的过表达诱导蛋白聚集和进行性剂量依赖性神经退行性变。
Mol Neurodegener. 2013 Nov 25;8:44. doi: 10.1186/1750-1326-8-44.
9
The central theme of Parkinson's disease: α-synuclein.帕金森病的核心主题:α-突触核蛋白。
Mol Neurobiol. 2013 Apr;47(2):460-5. doi: 10.1007/s12035-012-8369-3. Epub 2012 Nov 23.
10
Increased Levels of the Parkinson's Disease-Associated Gene ITPKB Correlate with Higher Expression Levels of α-Synuclein, Independent of Mutation Status.帕金森病相关基因 ITPKB 水平升高与 α-突触核蛋白表达水平升高相关,与突变状态无关。
Int J Mol Sci. 2023 Jan 19;24(3):1984. doi: 10.3390/ijms24031984.

引用本文的文献

1
The activation thresholds and inactivation kinetics of poking-evoked PIEZO1 and PIEZO2 currents are sensitive to subtle variations in mechanical stimulation parameters.刺激诱发的 PIEZO1 和 PIEZO2 电流的激活阈值和失活动力学对机械刺激参数的细微变化敏感。
Channels (Austin). 2024 Dec;18(1):2355123. doi: 10.1080/19336950.2024.2355123. Epub 2024 May 16.
2
Biochemical Fractionation of Human α-Synuclein in a Model of Synucleinopathies.人α-突触核蛋白在突触核蛋白病模型中的生化分离。
Int J Mol Sci. 2024 Mar 25;25(7):3643. doi: 10.3390/ijms25073643.